Champions Oncology
Oncology CRO with the largest bank of patient-derived xenograft models (TumorGraft), now adding 3D organoid screening and radiopharmaceutical services.
More than 1,400 clinically annotated PDX models with correlation to patient outcomes; TumorGraft3D organoid platform; AstraZeneca collaboration; fiscal 2026 revenue $59.4M (record) with positive adjusted EBITDA.
Pages like this
not linked directly; found by shared links- CompanyXilis
Shares Run the mouse or organoid trial at the same time as the human trial, Test drugs on the patient's own cancer cells when there is no trial to join, Patient-derived organoids, Preclinical models that do not predict people.
- IdeaAudit animal studies for randomisation and blinding, published by institution
Shares Multi-laboratory preclinical trials as the standard for go/no-go decisions, Patient-derived xenografts, Preclinical models that do not predict people.
- IdeaBuild laboratory models of the organs cancer spreads to
Shares Patient-derived xenografts, Patient-derived organoids, Preclinical models that do not predict people.
- IdeaBarcode patient-derived tumours to watch which clones win under each drug
Shares Patient-derived xenografts, Patient-derived organoids, Preclinical models that do not predict people.
- IdeaGrow models from tumour cells in the blood when a biopsy is impossible
Shares Patient-derived xenografts, Patient-derived organoids, Preclinical models that do not predict people.
- IdeaScore every model system on how well it predicted real trial results
Shares Patient-derived xenografts, Patient-derived organoids, Preclinical models that do not predict people.
- IdeaPick the laboratory model that matches the patient, not the one to hand
Shares Patient-derived xenografts, Patient-derived organoids, Preclinical models that do not predict people.
- IdeaAn open organoid bank for cancers too rare to have models
Shares Patient-derived xenografts, Patient-derived organoids, Preclinical models that do not predict people.